Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
Journal of Translational Medicine
|
November 17, 2018
Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors
Qi Luo, Guangyu Wei, Xiaoqing Wu, et al.
Frontiers in Oncology
|
July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study
Kunming Qi, Zhiling Yan, Hai Cheng, et al.
BMC Medicine
|
June 13, 2026
Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis
Fan Xia, Bin Lv, Xinyi Li, et al.
Frontiers in Immunology
|
May 8, 2023
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells
Yang Liu, Xingxing Jie, Li Nian, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
Wei Chen, Ying Wang, Kunming Qi, et al.
Frontiers in Immunology
|
May 2, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy
Lingling Yin, Bin Lv, Jiao Ge, et al.
Leukemia
|
June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection
Ying Wang, Yang Liu, Xu Tan, et al.
Cytotherapy
|
March 12, 2023
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
Sha Ma, Hujun Li, Dian Zhou, et al.
The Lancet. Haematology
|
August 6, 2019
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
Zhiling Yan, Jiang Cao, Hai Cheng, et al.
Clinical and Experimental Medicine
|
September 4, 2024
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Ruixue Ma, Qi Zhang, Yang Liu, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
Journal of Translational Medicine
|
November 17, 2018
Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors
Qi Luo, Guangyu Wei, Xiaoqing Wu, et al.
Frontiers in Oncology
|
July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study
Kunming Qi, Zhiling Yan, Hai Cheng, et al.
BMC Medicine
|
June 13, 2026
Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis
Fan Xia, Bin Lv, Xinyi Li, et al.
Frontiers in Immunology
|
May 8, 2023
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells
Yang Liu, Xingxing Jie, Li Nian, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
Wei Chen, Ying Wang, Kunming Qi, et al.
Frontiers in Immunology
|
May 2, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy
Lingling Yin, Bin Lv, Jiao Ge, et al.
Leukemia
|
June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection
Ying Wang, Yang Liu, Xu Tan, et al.
Cytotherapy
|
March 12, 2023
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
Sha Ma, Hujun Li, Dian Zhou, et al.
The Lancet. Haematology
|
August 6, 2019
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
Zhiling Yan, Jiang Cao, Hai Cheng, et al.
Clinical and Experimental Medicine
|
September 4, 2024
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Ruixue Ma, Qi Zhang, Yang Liu, et al.
Page
of 12